Stay updated on Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page.

Latest updates to the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe page history UI now shows Revision: v3.6.2 instead of v3.6.0. This reflects a small update to the study record history interface.SummaryDifference0.1%

- Check10 days agoChange DetectedThe References item in the Study Record Versions table was removed, altering how historical citations are displayed in the version history. This change affects navigation rather than the core study information.SummaryDifference0.1%

- Check17 days agoChange DetectedThe record history now includes the note 'No longer looking for participants' and the revision tag 'Revision: v3.6.0', while removing the previous 'Revision: v3.5.5' entry.SummaryDifference0.4%

- Check24 days agoChange DetectedAn updated platform version, v3.5.5, was added, replacing the prior v3.5.4. This indicates a deployment update to the site's underlying release.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History and the previous revision v3.5.3 was removed, signifying an editorial update to the page's metadata.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s displayed software/content revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than any study data update.SummaryDifference0.1%

Stay in the know with updates to Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page.